Multidisciplinary team directed analysis of whole genome sequencing reveals pathogenic non-coding variants in molecularly undiagnosed inherited retinal dystrophies

Author:

Daich Varela Malena12ORCID,Bellingham James1,Motta Fabiana13,Jurkute Neringa12,Ellingford Jamie M45,Quinodoz Mathieu678,Oprych Kathryn1,Niblock Michael1,Janeschitz-Kriegl Lucas67,Kaminska Karolina67,Cancellieri Francesca67,Scholl Hendrik P N67,Lenassi Eva45,Schiff Elena2,Knight Hannah2,Black Graeme45,Rivolta Carlo678,Cheetham Michael E1ORCID,Michaelides Michel12,Mahroo Omar A12ORCID,Moore Anthony T129,Webster Andrew R12,Arno Gavin1210

Affiliation:

1. UCL Institute of Ophthalmology , London EC1V 9EL , UK

2. Moorfields Eye Hospital , London EC1V 2PD , UK

3. Department of Ophthalmology, Universidade Federal de Sao Paulo , Sao Paulo 04021001 , Brazil

4. North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, St Mary’s Hospital , Manchester M13 9WL , UK

5. Division of Evolution and Genomic Sciences, Neuroscience and Mental Health Domain, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester M13 9PL , UK

6. Institute of Molecular and Clinical Ophthalmology Basel , Basel 4031 , Switzerland

7. Department of Ophthalmology, University of Basel , Basel 4031 , Switzerland

8. Department of Genetics and Genome Biology, University of Leicester , Leicester LE1 7RH , UK

9. University of California , San Francisco, CA 94607 , USA

10. North Thames Genomic Laboratory Hub, Great Ormond Street Hospital For Children , London WC1N 3JH , UK

Abstract

Abstract The purpose of this paper is to identify likely pathogenic non-coding variants in inherited retinal dystrophy (IRD) genes, using genome sequencing (GS). Patients with IRD were recruited to the study and underwent comprehensive ophthalmological evaluation and GS. The results of GS were investigated through virtual gene panel analysis, and plausible pathogenic variants and clinical phenotype evaluated by the multidisciplinary team (MDT) discussion. For unsolved patients in whom a specific gene was suspected to harbor a missed pathogenic variant, targeted re-analysis of non-coding regions was performed on GS data. Candidate variants were functionally tested by messenger RNA analysis, minigene or luciferase reporter assays. Previously unreported, likely pathogenic, non-coding variants in 7 genes (PRPF31, NDP, IFT140, CRB1, USH2A, BBS10 and GUCY2D), were identified in 11 patients. These were shown to lead to mis-splicing (PRPF31, IFT140, CRB1 and USH2A) or altered transcription levels (BBS10 and GUCY2D). MDT-led, phenotype-driven, non-coding variant re-analysis of GS is effective in identifying the missing causative alleles.

Funder

Moorfields Eye Charity

Stephen and Elizabeth Archer in memory of Marion Woods

National Eye Research Centre

National Institute of Health Research Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology

Fight For Sight UK Early Career Investigator Award

National Institute of Health Research Biomedical Research Centre at Great Ormond Street Hospital Institute for Child Health

National Institute for Health Research and NHS England

Medical Research Council

Swiss National Science Foundation

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Reference57 articles.

1. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom;Pontikos;Ophthalmology,2020

2. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases;Hanany;Proc. Natl. Acad. Sci. USA,2020

3. The impact of inherited retinal diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a cost-of-illness perspective;Galvin;Clin. Ophthalmol.,2020

4. A practical approach to retinal dystrophies;Tsui;Adv. Exp. Med. Biol.,2018

5. Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials;Daich Varela;Br. J. Ophthalmol.

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3